REGULATED PRESS RELEASE published on 05/13/2024 at 17:45, 4 months 15 days ago Disclosure of trading in own shares from May 6th, 2024, to May 10th, 2024. Detailed information per transaction Lagardère SA discloses trading in own shares from May 6th to May 10th, 2024, with detailed transaction information per day/hour Lagardère SA Trading Own Shares Transaction Information May 2024
REGULATED PRESS RELEASE published on 05/13/2024 at 17:45, 4 months 15 days ago Disclosure of trading in own shares from May 6th, 2024, to May 10th, 2024 Lagardère SA disclosed trading in its own shares from May 6th to May 10th, 2024, as per regulatory requirements. Details available at www.lagardere.com Trading Disclosure Lagardère SA Investor Relations Own Shares Regulations
BRIEF published on 05/06/2024 at 18:52, 4 months 22 days ago Lagardère SA Conducts Comprehensive Share Distribution to Employees Lagardère SA Financial Transactions Employee Shares Equity Distribution Corporate Incentives
BRIEF published on 05/06/2024 at 18:50, 4 months 22 days ago Lagardère SA Reports Recent Share Trading Activities Lagardère SA Investment Transparency Corporate Disclosure Share Trading Stock Market Activity
REGULATED PRESS RELEASE published on 05/06/2024 at 18:47, 4 months 22 days ago Disclosure of trading in own shares from April 29, 2024, to May 3rd, 2024. Detailed information per transaction Lagardère SA, a French joint-stock corporation, discloses trading in own shares from April 29 to May 3, 2024. Detailed information per transaction provided Lagardère SA Trading Own Shares French Joint-stock Corporation
REGULATED PRESS RELEASE published on 05/06/2024 at 18:45, 4 months 22 days ago Disclosure of trading in own shares from April 29, 2024, to May 3rd, 2024 Lagardère SA discloses own shares trading activities from April 29 to May 3, 2024, as per regulatory requirements Lagardère SA Disclosure Own Shares Regulatory Requirements Trading Activities
BRIEF published on 05/06/2024 at 17:50, 4 months 22 days ago LAGARDÈRE SA Updates on Voting Rights and Share Capital for April 2024 Share Capital Voting Rights French Commercial Code Lagardère SA AMF Regulations
REGULATED PRESS RELEASE published on 05/06/2024 at 17:45, 4 months 22 days ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL Lagardère SA releases monthly information on voting rights and share capital as of April 30, 2024, in compliance with French regulations Share Capital Voting Rights French Regulations Lagardère SA AMF
BRIEF published on 04/30/2024 at 19:48, 4 months 28 days ago Lagardère SA Announces Temporary Leadership Changes Lagardère SA Leadership Changes Arnaud Lagardère Jean-Christophe Thiery Constance Benqué
REGULATED PRESS RELEASE published on 04/30/2024 at 19:43, 4 months 28 days ago Provisional appointment to replace Arnaud Lagardère further to his ban from management activities. Lagardère SA appoints Jean-Christophe Thiery as Chairman and CEO following Arnaud Lagardère's provisional ban. Constance Benqué named President of Lagardère Commandité SAS Lagardère SA Arnaud Lagardère Jean-Christophe Thiery Constance Benqué Management Activities
Published on 09/28/2024 at 02:06, 23 hours 9 minutes ago Global Education Communities Corp. Reports Second Tranche Closing of Non-Brokered Private Placement
Published on 09/28/2024 at 02:00, 23 hours 15 minutes ago Quantum Biopharma Provides Corporate Update
Published on 09/28/2024 at 02:00, 23 hours 15 minutes ago bettermoo(d)’s Moodrink(TM) Featured in Banners of Well-Known Canadian Retailers
Published on 09/28/2024 at 00:10, 1 day 1 hour ago LQWD Technologies Announces Non-Brokered Private Placement Update
Published on 09/28/2024 at 14:01, 11 hours 13 minutes ago Turkiye Garanti Bankasi A.S.: Explanation on Subordinated Debt Securities to Qualified Investors
Published on 09/27/2024 at 22:30, 1 day 2 hours ago DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Published on 09/27/2024 at 21:56, 1 day 3 hours ago EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Published on 09/27/2024 at 18:50, 1 day 6 hours ago PETROFAC ANNOUNCES IN-PRINCIPLE AGREEMENT ON FINANCIAL RESTRUCTURE
Published on 09/27/2024 at 18:40, 1 day 6 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/27/2024 at 17:45, 1 day 7 hours ago NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
Published on 09/26/2024 at 18:00, 2 days 7 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2024
Published on 09/26/2024 at 18:00, 2 days 7 hours ago GUILLEMOT CORPORATION: 2024 CONSOLIDATED INTERIM RESULTS
Published on 09/26/2024 at 17:47, 2 days 7 hours ago imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024